Distribution Characteristics and Prognostic Value of Immune Infiltration in Oligometastatic Breast Cancer

被引:3
作者
Zhou, Danyang [1 ]
Jiang, Kuikui [1 ]
Hong, Ruoxi [1 ]
Lu, Qianyi [1 ]
Xia, Wen [1 ]
Li, Mei [2 ]
Zheng, Chengyou [2 ]
Zheng, Qiufan [1 ]
Xu, Fei [1 ]
Wang, Shusen [1 ]
机构
[1] Sun Yat Sen Univ, Canc Ctr, State Key Lab Oncol South China, Dept Med Oncol,Collaborat Innovat Ctr Canc Med, Guangzhou, Peoples R China
[2] Sun Yat Sen Univ, Canc Ctr, State Key Lab Oncol South China, Dept Pathol,Collaborat Innovat Ctr Canc Med, Guangzhou, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2021年 / 11卷
基金
中国国家自然科学基金;
关键词
immune infiltration; primary tumor; oligometastatic lesion; intratumoral; peritumoral; prognostic value; oligometastatic breast cancer; COLORECTAL-CANCER; T-CELLS; SURVEILLANCE; LYMPHOCYTES; MECHANISMS; LANDSCAPE; DISEASE;
D O I
10.3389/fonc.2021.747012
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundTo assess the distribution characteristics and the prognostic value of immune infiltration in female oligometastatic breast cancer patients. MethodsWe retrospectively analyzed the clinicopathological data of oligometastatic breast cancer (OMBC) patients diagnosed between June 2000 and January 2020. Immune markers were quantified by immunohistochemistry on FFPE tissues in paired normal breast tissues, primary breast cancers and oligometastatic lesions. Survival analyses were performed using the Kaplan-Meier curves and Cox-proportional hazards model. ResultsA total of 95 female OMBC patients visited Sun Yat-sen University Cancer Center between June 2000 and January 2020, and 33 of them had matched normal breast tissues, primary cancers and oligometastatic lesions and were reviewed in immune infiltration analysis. CD8 of primary tumors had a higher expression than that in matched normal tissues. The expressions of CD8 and FOXP3 were higher in the primary sites than that in the oligometastatic lesions. CD3, CD4 and CD8 were significantly lower in the intratumoral regions than that in the peritumoral regions both in primary and oligometastatic lesions. Notably, the high percentage of CD3 in the intratumoral oligometastatic lesions predicted the longer PFS and OS, and higher CD4 in the same lesions also predicted a better OS. There was obviously positive correlation between CD4/CD3 and Ki-67 in primary cancers and negative correlation between CD4/CD3 and ER in oligometastatic sites. ConclusionWe explored immune distribution and evolution in time and space in OMBC to provide new understandings for biological behaviors of this disease and further divided patients in different prognosis.
引用
收藏
页数:11
相关论文
共 50 条
  • [2] BURNET FM, 1970, PROG EXP TUMOR RES, V13, P1
  • [3] 4th ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)
    Cardoso, F.
    Senkus, E.
    Costa, A.
    Papadopoulos, E.
    Aapro, M.
    Andre, F.
    Harbeck, N.
    Aguilar Lopez, B.
    Barrios, C. H.
    Bergh, J.
    Biganzoli, L.
    Boers-Doers, C. B.
    Cardoso, M. J.
    Carey, L. A.
    Cortes, J.
    Curigliano, G.
    Dieras, V.
    El Saghir, N. S.
    Eniu, A.
    Fallowfield, L.
    Francis, P. A.
    Gelmon, K.
    Johnston, S. R. D.
    Kaufmann, B.
    Koppikar, S.
    Krop, I. E.
    Mayer, M.
    Nakigudde, G.
    Offersen, B. V.
    Ohno, S.
    Pagani, O.
    Paluch-Shimon, S.
    Penault-Llorca, F.
    Prat, A.
    Rugo, H. S.
    Sledge, G. W.
    Spence, D.
    Thomssen, C.
    Vorobiof, D. A.
    Xu, B.
    Norton, L.
    Winer, E. P.
    [J]. ANNALS OF ONCOLOGY, 2018, 29 (08) : 1634 - 1657
  • [4] Prognostic value of tumor infiltrating lymphocyte subsets in breast cancer depends on hormone receptor status
    Chung, Yul Ri
    Kim, Hyun Jeong
    Jang, Min Hye
    Park, So Yeon
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2017, 161 (03) : 409 - 420
  • [5] Immune approaches to the treatment of breast cancer, around the corner?
    Criscitiello, Carmen
    Esposito, Angela
    Gelao, Lucia
    Fumagalli, Luca
    Locatelli, Marzia
    Minchella, Ida
    Adamoli, Laura
    Goldhirsch, Aron
    Curigliano, Giuseppe
    [J]. BREAST CANCER RESEARCH, 2014, 16 (01):
  • [6] Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy
    Denkert, Carsten
    von Minckwitz, Gunter
    Darb-Esfahani, Silvia
    Lederer, Bianca
    Heppner, Barbara I.
    Weber, Karsten E.
    Budczies, Jan
    Huober, Jens
    Klauschen, Frederick
    Furlanetto, Jenny
    Schmitt, Wolfgang D.
    Blohmer, Jens-Uwe
    Karn, Thomas
    Pfitzner, Berit M.
    Kuemmel, Sherko
    Engels, Knut
    Schneeweiss, Andreas
    Hartmann, Arndt
    Noske, Aurelia
    Fasching, Peter A.
    Jackisch, Christian
    van Mackelenbergh, Marion
    Sinn, Peter
    Schem, Christian
    Hanusch, Claus
    Untch, Michael
    Loibl, Sibylle
    [J]. LANCET ONCOLOGY, 2018, 19 (01) : 40 - 50
  • [7] Tumor-Associated Lymphocytes As an Independent Predictor of Response to Neoadjuvant Chemotherapy in Breast Cancer
    Denkert, Carsten
    Loibl, Sibylle
    Noske, Aurelia
    Roller, Marc
    Mueller, Berit Maria
    Komor, Martina
    Budczies, Jan
    Darb-Esfahani, Silvia
    Kronenwett, Ralf
    Hanusch, Claus
    von Toerne, Christian
    Weichert, Wilko
    Engels, Knut
    Solbach, Christine
    Schrader, Iris
    Dietel, Manfred
    von Minckwitz, Gunter
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (01) : 105 - 113
  • [8] Long-term outcomes in radically treated synchronous vs. metachronous oligometastatic non-small-cell lung cancer
    Fleckenstein, Jochen
    Petroff, Alev
    Schaefers, Hans-Joachim
    Wehler, Thomas
    Schoepe, Jakob
    Ruebe, Christian
    [J]. BMC CANCER, 2016, 16
  • [9] Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer - Analysis of 1001 consecutive cases
    Fong, Y
    Fortner, J
    Sun, RL
    Brennan, MF
    Blumgart, LH
    [J]. ANNALS OF SURGERY, 1999, 230 (03) : 309 - 318
  • [10] Differential intratumoral distributions of CD8 and CD163 immune cells as prognostic biomarkers in breast cancer
    Fortis, Sotirios P.
    Sofopoulos, Michael
    Sotiriadou, Nectaria N.
    Haritos, Christoforos
    Vaxevanis, Christoforos K.
    Anastasopoulou, Eleftheria A.
    Janssen, Nicole
    Arnogiannaki, Niki
    Ardavanis, Alexandros
    Pawelec, Graham
    Perez, Sonia A.
    Baxevanis, Constantin N.
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5